Trial intelligence / Profile preview

Magnesium Sulfate Injection for Myofascial Pain

NCT06975813Phase 2Not yet recruiting

Sponsor
Fayoum University
Start
Jun 2025
Primary completion
Dec 2025
Modality
Small Molecules
01

Overview

A Phase 2 trial of magnesium sulfate in myofascial pain syndrome (MPS), sponsored by Fayoum University. Planned start Jun 2025; status: not yet recruiting.

02

Drugs

magnesium sulfate
03

Conditions

myofascial pain syndrome (MPS)

Beyond the preview

Go deeper on NCT06975813.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06975813.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call